Please leave this field empty
(800) 458-6223 info@curesearch.org
Select Page

Our Research Strategy

Introduction to the CureSearch Research Strategy

CureSearch launched a game-changing strategy that directly addresses the largest obstacles impeding medical progress. Our research strategy was brought forth to address two major problems that exist today:

Problems with lack of cancer treatments for children

At CureSearch, we are driven to deliver better treatments for children NOW. Children deserve access to cancer-curing therapies made for their little bodies. They deserve a life without destructive side effects or secondary diseases. They deserve to live the rest and best of their lives.

CureSearch recognizes we need to change a broken system. We have the key players in place and your fundraising dollars will help us get there. Donate to support our strategy that accelerates treatments.

To accomplish our research vision, we launched our Research Strategy:

The CureSearch Difference

We're doing things differently to change the status quo in the pediatric cancer realm. Through our Research Strategy:

  • We break down barriers by bringing together groups that traditionally don’t work together – scientists, pharmaceutical companies, regulatory agencies (like the FDA) and build partnerships with one mutual end goal: new, safer treatments to kids.
  • Dollars raised are put towards early-stage research, translational research and pediatric cancer clinical trials with the highest potential so treatments can be fast-tracked to children.
  • We support researchers through funding, as well as through guidance, knowledge, and relationships to navigate the regulatory environment and clinical trials network to ensure the greatest chance of success.

CureSearch Strategy Research Programs

The Research Funding Pipeline

Our research programs are focused on saving kids. We identify and fund high-potential research projects with an aggressive timeline to meet our end goal — developing treatments to save kids now. We do this through our:

  • Young Investigators portfolio where we provide seed funding for bright researchers, early in their careers, pursuing exciting novel ideas.
  • Acceleration Initiative program which addresses the largest obstacles in children's cancer research, driving translational research to the clinic.
  • Catapult Awards that advance the strongest research into clinical trials and ultimately drug development.
  • CureSearch won't stop until more and better children's cancer treatments are out of the lab and into the clinic and commercialization, ensuring more children live long, healthy and productive lives.

    CureSearch Research FAQs

    Expand all sections   Close all sections

    What is the CureSearch Research Strategy?

    Our Research Strategy quickly advances the strongest children’s cancer research and accelerate real treatments to the marketplace for children. Simply put, the treatment development system is broken. Relationships between academic scientists, drug developers, and policy regulators to advance new treatments do not exist. CureSearch has stepped up to drive the collaborations needed to push forward our mutual goal: to deliver less-toxic treatments to kids NOW.

    How does the Strategy work?

    The CureSearch Research Strategy works by:

    • Breaking down barriers and creating partnerships between all the necessary players, to advance better, less toxic children’s cancer treatments (researchers, pharmaceutical companies, regulatory agencies, patients/families, healthcare providers, supporters, advocates)
    • Funding early-stage research, translational research and pediatric cancer phase I and II clinical trials with the highest potential and addressing the greatest unmet medical need.
    • Supporting researchers through funding, but also through guidance, knowledge, and relationships to navigate the regulatory environment and clinical trials network to ensure the greatest chance of success.

    How is CureSearch Research Strategy different?

    Research breakthroughs are rarely set up to translate into drug development. CureSearch’s strategy addresses this gap, supporting researchers with the funding, knowledge and connections they need to successfully take their research into clinical trials and development.

    Our strategy not only funds high-potential research that is engineered at all stages to advance to the marketplace, but also breaks down barriers and builds the relationships needed to push forth treatments. We’re bringing together collaborations needed to drive our mutual goal: delivering less-toxic treatments to kids.

    How is Catapult Strategy different

    How does our strategy break down barriers?

    CureSearch has stepped up to drive the collaborations needed to push forward drug development for children’s cancer. As the only neutral convener in pediatric cancer, CureSearch brings together academia, regulatory agencies, healthcare, pharmaceutical, industry agencies and families.

    CureSearch hosts the Catapult Summit, a strategic annual meeting with the most innovative minds in science, drug development, advocacy, and health funding to focus on one very important goal: getting more and better treatments to children with cancer. The Summit convenes leaders, identifies obstacles to advancing children’s cancer treatments and develop a strategy to directly address these hurdles.

    Additionally, CureSearch is developing a vital online website portal that will facilitate resources and collaborations that advance pediatric cancer treatments.

    Who funds CureSearch's Research Strategy?

    With little federal funding, crucial research is funded primarily by supporters like you. We seek financial support from funders who believe, as we do, that it is necessary to catapult great research out of the lab and to children. By joining us, you become part of a visible, powerful team fighting loudly and courageously for cures.

    Why now?

    Despite years of funding, progress in the fight against children’s cancer has been slow. In fact, each year more than 15,000 children in the U.S. alone are diagnosed with cancer, and options are few. To save their child’s life, parents often have to consent to today’s toxic therapies, knowing debilitating side effects are likely to follow their child throughout his or her life — side effects such as infertility, onset of heart disease at an early age, or a secondary, life-threatening cancer.

    Too many children are dying or suffering devastating side effects from their too-toxic treatments — children deserve better, and NOW.

    What do the experts think?

    This video, filmed at our annual Catapult Summit, shows testimonials on the importance and strength of the CureSearch Strategy from experts in pediatric oncology:

    “Childhood cancer continues to be the number one disease killer of children; through our research strategy, we are directly funding research that will drive new treatments to the marketplace for the kids who need it most,” said Kay Koehler, CureSearch CEO. “We are funding only the most promising therapies that show a strong potential for future approval and commercialization.”

    How can I help?

    We know where the problems lie and how to overcome them. We are building the tools and resources and have marshaled the talent to change the future of pediatric cancer research and drug development. With the help of philanthropic donors and investors, we can do it exponentially better and faster.

    You can help us deliver better treatments for children faster by donating toward CureSearch’s lifesaving strategy. Get involved and give today so children can live longer, healthier lives tomorrow.

    Where can researchers apply for funding?

    The Catapult Awards RFA period is closed but be sure to check back for updates. Click to learn about current Young Investigator and Acceleration Initiative projects.

    Contact Us

    Interested in learning more about the CureSearch Strategy? Email National Director, Business Development Kelli Wright.

    Our Research Strategy was last modified: May 14th, 2018 by Geoff Duncan
Menu

Pin It on Pinterest